NCT00577395View on ClinicalTrials.gov

Bone Microarchitecture in Osteopenic Postmenopausal Women

PHASE4TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Osteoporosis
Interventions
DRUG

placebo

oral tablet once a month for 12 months

DRUG

risedronate

tablet, 150 mg once a month for 12 months

Trial Locations (4)

45201

Research Site, Cincinnati

68729

Research Facility, Omaha

85704

Research Facility, Tuscon

Unknown

Research Facility, Buenos Aires

Sponsors

Lead Sponsor

Warner Chilcott

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Warner Chilcott

INDUSTRY